Article published by : FutureWise on Wednesday, July 03, 2019 - Viewed 309 times

Category : Health & Fitness

Fascioliasis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities, And Market Forecast 2019 To 2026

Infections in humans and cattle due to food-borne parasites are widespread across the globe. Fascioliasis or liver fluke infection is prevalent amongst children, cattle and sheep in rural livestock rearing parts of the world like Peru, Vietnam, Bolivia, Egypt, Ecuador and Iran. The only way to intercept the transmission of Fascioliasis in endemic areas is through WHO (World Health Organisation) suggested anti-fascioliasis drugs like Triclabendazole. However, resistance to this WHO recommended drug and toxicity dangers associated with hexachloro-para-xylol, emetine, niclofolan, chloroquine, etc. has opened doors to the discovery of alternative medicines like Nitazoxanide.
Furthermore, fascioliasis interfered with chronic conditions like ascending cholangitis are a challenge as they need appropriate antibacterial antibiotics. Thus in accordance with combat against the adverse consequences on public health and eventually socio-economic progress pharmaceutical companies are striving to provide a viable solution to neglected tropical disease.
With the support from WHO and government bodies, global fascioliasis treatment market players can gain critical missing information about unsafe food that can help in drug innovation for Fascioliasis treatment. The research experts at FutureWise predicted a robust CAGR for the global fascioliasis treatment market during the forecast period 2019-2026

Request a Sample Report @

Global Fascioliasis Treatment Market, by Treatment Type
• Standard Therapy
• Supportive Therapy
At present standard therapy holds the major global fascioliasis treatment market as significant dosage complications and temporary post-treatment side effects are issues better handled by standard therapy. The R&D efforts and investments for suitable standard drug discovery are estimated to augment standard therapy segment in the upcoming period. Also, WHO initiatives and support to provide free of cost drug in developing nations of endemic regions are to affect the growth of the market.

Global Fascioliasis Treatment Market, by End-User
• Hospitals
• Clinics
• Personalised cares

Global Fascioliasis Treatment Market, by Region
• North America
• Latin America
• Europe
• Asia Pacific
• Rest of the World
Due to stringent sanitation policies and high food quality standards, North America and Europe are to experience negligible CAGR in the near future. The high dependency on animal food souces, lack of awareness about hazards of raw vegetables and meat consumption and insufficient measures to curb the epidemic arer factors that would triumph the robust CAGR in APAC and Latin America region.

Purchase a Copy of this Premium Research Report At:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global fascioliasis treatment market on the basis of treatment type, distribution channel, and region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Inquire further details about this report at:

About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom


By: FutureWise

Article Directory:

Copy and Paste Link Code:

Read other Articles from FutureWise: More »

Article ID 1078887 (Views 309)

Announcement from Our Sponsor

Cancer Drugs like Lenvima (generic version Lenvatinib), Imbruvica (generic version Ibrutinib) now have generic versions at tremendous savings. Brain boosting drugs like Provigil (generic version Modafinil) and Nuvigil (generic version Armodafinil) are also popular.

Sponsor Listing Canadian Pharmacy